ArticleScientific reports2025
Transformer-based representation learning for robust gene expression modeling and cancer prognosis.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Transcriptome graph transformer: a graph transformer-based unsupervised model for transcriptome data analysis.BMC bioinformatics · 2026Article
- Exploring machine learning strategies for single-cell transcriptomic analysis in wound healing.Burns & trauma · 2025Review
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Transformer models have achieved remarkable success in natural language and vision tasks, but their application to gene expression analysis remains limited due to data sparsity, high dimensionality, and missing values. We present GexBERT, a transformer-based encoder-decoder framework for robust representation learning of gene expression data. GexBERT learns context-aware gene embeddings by pretraining on large-scale transcriptomic profiles with a masking and restoration objective that captures co-expression relationships among thousands of genes. We evaluate GexBERT across three critical tasks in cancer research: pan-cancer classification, cancer-specific survival prediction, and missing value imputation. GexBERT achieves state-of-the-art classification accuracy from limited gene subsets, improves survival prediction by restoring expression of prognostic anchor genes, and outperforms conventional imputation methods under high missingness. These findings demonstrate the utility of GexBERT as a scalable and effective tool for gene expression modeling, with translational potential in settings where gene coverage is limited or incomplete.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.